25 of the Best Oncologists Near Me in Rockville Centre, NY

Francisco Esteva is an Oncologist practicing medicine in New York, New York. Dr. Esteva is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Paget Disease of the Breast. Dr. Esteva is board certified in American Board Of Internal Medicine/Medical Oncology. Dr. Esteva is currently accepting new patients.

Sandra D'angelo is an Oncologist practicing medicine in New York, New York. Dr. D'angelo is highly rated in 33 conditions, according to our data. Her clinical expertise encompasses Synovial Sarcoma, Adult Soft Tissue Sarcoma, Liposarcoma, Merkel Cell Carcinoma, and Liver Embolization. Dr. D'angelo is currently accepting new patients.

Mark Dickson is an Oncologist practicing medicine in New York, New York. Dr. Dickson is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Undifferentiated Pleomorphic Sarcoma, Synovial Sarcoma, and Endoscopy. Dr. Dickson is currently accepting new patients.

Nicole Lamanna, MD, is an Associate Clinical Professor of Medicine in the Hematologic Malignancies Section of the Hematology/Oncology Division. Dr. Lamanna is a hematologist/oncologist whose research interests include lymphoid leukemias, specifically chronic lymphocytic leukemia. She is an experienced clinical investigator and her research focus has been the development of combination therapies that include chemoimmunotherapy, immunomodulatory drugs, novel kinase inhibitors and monoclonal antibodies. She also is working to find active, safer therapies for older patients with these diseases. She earned her medical degree from Albert Einstein College of Medicine and completed her fellowship in Hematology-Oncology at Memorial Sloan-Kettering Cancer Center. Dr. Lamanna is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Bone Marrow Aspiration, and Gastrostomy. Dr. Lamanna is board certified in Medical Oncology. Dr. Lamanna is currently accepting new patients.

Paul Oberstein is an Oncologist practicing medicine in New York, New York. Dr. Oberstein is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Colorectal Cancer, and Stomach Cancer.

Joshua Sabari is an Oncologist practicing medicine in New York, New York. Dr. Sabari is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Tissue Biopsy, and Thrombectomy.

Mrinal Gounder is an Oncologist practicing medicine in New York, New York. Dr. Gounder is highly rated in 32 conditions, according to our data. His clinical expertise encompasses Desmoid Tumor, Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, Liposarcoma, and Liver Embolization. Dr. Gounder is currently accepting new patients.

Yukio Sonoda is a Gynecologic Oncologist and an Oncologist practicing medicine in New York, New York. Dr. Sonoda is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Hysterectomy, and Lymphadenectomy. Dr. Sonoda is currently accepting new patients.

Jasmine Zain is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Zain is highly rated in 29 conditions, according to our data. Her clinical expertise encompasses T-Cell Lymphoma, Peripheral T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Zain is currently accepting new patients.

Christian Grommes is an Oncologist practicing medicine in New York, New York. Dr. Grommes is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Primary Lymphoma of the Brain, Non-Hodgkin Lymphoma, Brain Tumor, Vitrectomy, and Bone Marrow Aspiration. Dr. Grommes is currently accepting new patients.

Eli Diamond is an Oncologist practicing medicine in New York, New York. Dr. Diamond is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Reticulohistiocytoma, Rosai-Dorfman Disease, Glioblastoma, Astrocytoma, and Awake Craniotomy. Dr. Diamond is currently accepting new patients.

Ellin Berman is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Berman is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Chronic Myelogenous Leukemia (CML), Leukemia, Acute Myeloid Leukemia (AML), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Berman is currently accepting new patients.

Anas Younes is an Oncologist practicing medicine in New York, New York. Dr. Younes is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Hodgkin Lymphoma, and B-Cell Lymphoma.

Arjun Balar is an Oncologist practicing medicine in New York, New York. Dr. Balar is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Bladder Cancer, Prostate Cancer, Muscle Invasive Bladder Cancer, and Thrombectomy.

Hamza Hashmi is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Hashmi is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Hashmi is currently accepting new patients.

Vamsidhar Velcheti is an Oncologist practicing medicine in New York, New York. Dr. Velcheti is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration.

Mark Frattini is an Oncologist practicing medicine in New York, New York. Dr. Frattini is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Chronic B-Cell Leukemia (CBCL), Leukemia, and Bone Marrow Aspiration.

David Wise is an Oncologist practicing medicine in New York, New York. Dr. Wise is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, and Bladder Cancer.

Jonathan Kolitz, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in malignant hematology, he is the System Head for Malignant Hematology for the Northwell Health Cancer Institute where he guides the clinical care and research activities of faculty and fellows. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Kolitz has been a member of the Leukemia Core Committee of the CALGB/Alliance since 1993. He has focused on the development, conduct and publication of innovative clinical trials for the treatment of hematologic malignancies, especially acute leukemia. He has been principal investigator for numerous novel drug trials and has been involved in multiple national and international collaborations, leading to over 200 publications. As an attending physician at the Monter Cancer Center, Dr. Kolitz focuses on providing compassionate, personalized, evidence-based care. Dr. Kolitz earned his medical degree from the Yale University School of Medicine. He trained in Internal Medicine at North Shore University Hospital and Hematology and Medical Oncology at Memorial Sloan-Kettering Cancer Center. Dr. Kolitz is an active member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. Dr. Kolitz is highly rated in 48 conditions, according to our data. His clinical expertise encompasses Leukemia, Chronic B-Cell Leukemia (CBCL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Aspiration. Dr. Kolitz is board certified in American Board Of Internal Medicine/Medical Oncology, American Board Of Internal Medicine, and American Board Of Internal Medicine/Hematology. Dr. Kolitz is currently accepting new patients.

Nagashree Seetharamu, MD, MBBS, is an Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology, Medical Oncology and Hospice/Palliative medicine, she specializes in cancers of the head and neck and thoracic malignancies (lung cancer, mesothelioma, thymic tumors). She maintains an active clinical practice at the Monter Cancer Center where she focuses on providing compassionate, personalized, evidence-based multidisciplinary care. Dr. Seetharamu has established her reputation at the national level through her active involvement, and leadership within influential oncology organizations that steer the direction of clinical cancer care and research across the United States, and globally. She is a full member of both the Cancer Prevention Committee and Respiratory Committee of Alliance for Clinical Trials in Oncology. This is a national, NCI-sponsored, cooperative group that develops, fund and conducts clinical trials at many academic and community oncology centers across the country. In her position on these committees, she collaborates with clinical research experts across the country to establish standards-of-care, oversees the conduct of existing clinical trials, develops innovative and impactful hypotheses, and formulate future clinical trials. Dr. Seetharamu is the institutional principal investigator on over 10 clinical trials, has co-authored over 50 publications and book chapters and is a sought after speaker at various regional, national and international events related to Head and Neck and Thoracic cancer. Dr. Seetharamu is also Associate Program Director of the Medical Oncology and Hematology Fellowship Program for the Northwell Health Cancer Institute. In this role, she provides hands-on involvement in the recruitment, education and mentorship of future generations of physicians. Dr. Seetharamu trained in internal medicine at Long Island Jewish Medical Center and in hematology/oncology at New York University Medical Center. Dr. Seetharamu is highly rated in 28 conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Seetharamu is board certified in American Board Of Internal Medicine/Medical Oncology, American Board Of Internal Medicine, American Board Of Internal Medicine/Hospice & Palliative Medicine, and American Board Of Internal Medicine/Hematology. Dr. Seetharamu is currently accepting new patients.

Douglas Gladstone is an Oncologist and a Transplant Surgeon practicing medicine in Lake Success, New York. Dr. Gladstone is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Hairy Cell Leukemia (HCL), Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Gladstone is currently accepting new patients.

Louis Kavoussi, MD, MBA, Director of teleintervention at Northwell. He is a world-renowned urologic surgeon who brings more than 30 years of specialized expertise in minimally invasive urological surgery. His area of focus includes treating a wide range of urologic diseases, including kidney obstructions, renal stones and urologic cancer. At the forefront of innovation, Dr. Kavoussi pioneered several new surgical techniques, including the first minimally invasive approaches to kidney surgery for kidney cancer and kidney donation. He was also part of the team that performed the first laparoscopic prostate removal for cancer. In 1999, Dr. Kavoussi received a Smithsonian Computerworld Permanent Collection award for his work in developing telerounding, the starting point of telehealth medicine-to facilitate physician communication with hospitalized patients. Before joining Northwell in 2005 as chair of urology, Dr. Kavoussi completed his medical degree at the State University of New York at Buffalo. He obtained his urologic training at Washington University of St. Louis and, directly following residency, was named chief of urology at the Jewish Hospital of St. Louis. In 1991, he was appointed assistant professor at Harvard School of Medicine and director of endourology at the Brigham and Women's Hospital. In 1993, he joined the faculty of Johns Hopkins University School of Medicine, where he was vice chairman of urology and named a Patrick C. Walsh Distinguished Professor. Dr. Kavoussi values a team approach to care, and often collaborates with other specialists to create personalized and comprehensive treatment plans. His patients appreciate his easygoing personality and thoughtfulness. As the Waldbaum-Gardner Distinguished Professor of Urology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dr. Kavoussi is passionate about training the next generation of surgeons. He has presented his work and given live surgical demonstrations at conferences around the world and has more than 500 academic publications. Dr. Kavoussi is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery. Dr. Kavoussi is board certified in American Board Of Urology. Dr. Kavoussi is currently accepting new patients.

Dr. Howard Goodman is Chief of the Musculoskeletal Oncology Service in the Orthopaedic Institute of Northwell Health and is an assistant professor at the Zucker School of Medicine at Hofstra / Northwell. His clinical practice includes benign and malignant tumors of the bones and soft tissue in the arms and legs, as well as treatment for bony metastatic disease.Dr. Goodman is a native New Yorker, and has spent his professional career caring for orthopaedic tumor patients in New York City and Long Island. He earned a bioengineering degree with honors from the University of Pennsylvania, his medical degree from the Albert Einstein College of Medicine, trained in Orthopaedics at Maimonides Medical Center, where he served as chief resident for a year and a half, and did postgraduate training in Musculoskeletal Oncology and Limb Salvage Surgery at UMDNJ New Jersey Medical School.Dr. Goodman is active with Northwell Cancer Institute initiatives, including running the multidisciplinary Sarcoma / Bone & Soft tissue Tumor Board. He has organized and run an annual Orthopaedic Pathology review course for the residents. He is on the faculty of 3 orthopaedic residencies as well as fellowships in Orthopaedic Joint Reconstruction, General Surgical Oncology and PMR Oncology Rehabilitation. Dr. Goodman has written multiple articles and book chapters and serves as a journal editor for orthopaedic oncology. He is a fellow of the American Academy of Orthopaedic Surgeons, and a member of the Musculoskeletal Tumor Society, International Skeletal Society, International Society of Limb Salvage Surgery and the New York Society of Orthopaedic Surgeons.Dr. Goodman s practice centers around patient based individualized care, with both operative and nonoperative considerations. He is involved in developing new surgical techniques and 3D printed anatomic models, instruments and implants. He believes in combining biologic with implant reconstruction options for allowing best outcomes for his patients. He has been listed as a Castle Connolly Top Doctor for more than 5 years. Dr. Goodman is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Chondroma, Osteochondroma, Fibrosarcoma, Bone Tumor, and Hip Replacement. Dr. Goodman is board certified in American Board Of Orthopaedic Surgery. Dr. Goodman is currently accepting new patients.

Dr. Owen A. O'Connor is internationally renowned for his expertise on the diagnosis and treatment of all forms of lymphoma, with over 25 years of experience in academic medicine. He has invented and pioneered the development of several first in class drugs for the treatment of lymphoma, including one he co-invented for T-cell lymphoma which has now been approved in over 35 countries around the world. He has held several prestigious leadership positions at the major cancer centers in New York City, including Memorial Sloan Kettering Cancer Center, New York University Medical Center, and Cornell and Columbia University Medical Centers. Dr. O'connor is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Non-Hodgkin Lymphoma, and Anaplastic Large Cell Lymphoma. Dr. O'connor is currently accepting new patients.

Veena John, MD, is the System Head for GYN/Medical Oncology for the Northwell Health Cancer Institute and an Assistant Professor of Medicine in the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology and Medical Oncology, she maintains an active practice caring for patients with gynecologic cancers where she focuses on providing compassionate, personalized, evidence-based multi-disciplinary care. In conjunction with physicians in Surgical Oncology, she pioneered a multi-disciplinary team approach for gynecologic oncology patients at the R.J. Zuckerberg Cancer Center where her practice is based. Dr. John is a highly experienced principal investigator for industry sponsored Phase I, II and III clinical trials in gynecologic oncology. She is the site principal investigator for the NRG cooperative group for the Northwell Health Cancer Institute and co-chair of the protocol review monitoring committee. Dr. John earned her medical degree from Christian Medical College in India, where she also completed her internal medicine internship. She completed her internal medicine residency at Flushing Medical Center and fellowship in hematology and medical oncology at North Shore University Hospital. She is an active member of the Society for Gynecologic Oncology, Society for Immunotherapy in Cancer, American Society of Clinical Oncology and American Society of Hematology as well as a member of the Ovarian Cancer committee for the national Gynecologic Oncology Group. Dr. John is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Testicular Yolk Sac Tumor, and Malignant Mixed Mullerian Tumor. Dr. John is board certified in American Board Of Internal Medicine/Medical Oncology, American Board Of Internal Medicine, and American Board Of Internal Medicine/Hematology. Dr. John is currently accepting new patients.